Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today declared the launch of ENDO-Assist*one, a chopping-edge system powered by artificial intelligence (AI) that incorporates the endoscopy software ENDO-Assist CADe (pc-aided detection) for the colon.
This new AI system allows authentic-time show of quickly detected suspicious lesions and works in blend with Olympus’ recently introduced EVIS X1, its most state-of-the-art endoscopy method to date.
As a world chief in planning and providing revolutionary options for health care and surgical methods, Olympus aims to increase the wellbeing and good quality of existence of individuals by furnishing state-of-the-art health care technologies. Its most current endoscopy method, EVIS X1, was made to established new requirements for impression detection, characterization, staging, and cure.
With the recently introduced endoscopy CAD (pc-aided detection/prognosis) system ENDO-Assist, Olympus is now boosting the capabilities of EVIS X1 by AI technology, aiming to elevate the common of endoscopy around the entire world – whether or not for programs to disorders of the esophagus, tummy, colon or other gastrointestinal organs.
ENDO-Assist CADe: authentic-time pc-aided detection for endoscopy
ENDO-Assist CADe is an software for pc-aided detection powered by AI which runs on ENDO-Assist. It makes use of a complicated algorithm by way of a neural network made and experienced by Olympus. With this new software, the system’s sophisticated device mastering can inform the endoscopist in authentic time when a suspected colonic lesion (such as a polyp, malignant neoplasm or adenoma) seems on the display screen.
ENDO-Assist CADe was made towards the following improvements:
- Improved observational overall performance in adenoma detection: By furnishing visible support, ENDO-Assist CADe aims to increase the observational overall performance of the endoscopist’s adenoma detection.
- Assistance of the colonoscopy screening procedure: The method presents visible support in the course of screening, enabling the endoscopist to aim on any abnormalities indicated by the software irrespective of the experience stage of the endoscopist.
- Economical endoscopy operation: Thanks to the easy and intuitive show of lesions, ENDO-Assist CADe has the prospective to make endoscopy simpler and much more efficient for the endoscopist by reducing the will need for excessive eye actions.
A first phase in direction of the upcoming of endoscopic prognosis and therapy
With ENDO-Assist, the most current function of the EVIS X1 endoscopy method, Olympus has established the foundation and infrastructure for the installation of upcoming programs supported by AI. “At Olympus we are fully commited to innovation and driving our investigate and improvement with enthusiasm,” claims Frank Drewalowski, Head of Endoscopic Alternatives Division, Olympus Corporation. “Especially in AI, we realize the ability of elevating endoscopic imaging to uncharted degrees. Looking at ENDO-Assist as a first phase, we are setting up added AI-powered programs for impression detection and characterization – not only for colonoscopy.”
Prevention of colorectal most cancers continues to be our aim
There is a positive effects of an enhance in adenoma detection rate (ADR) on the avoidance of colorectal most cancers (CRC)*2. Supporting the identification of lesions, ENDO-Assist CADe is intended to enhance ADR*3. We are aiming to enhance the good quality of CRC screening and its preventive efficacy versus CRC. The avoidance of CRC is a core aspect of Olympus’ endeavors in health care endoscopy and beyond.
“With the launch of ENDO-Assist, we are not only furnishing endoscopists across the entire world with an added revolutionary software,” claims Takaharu Yamada, Vice President, GI Endoscopy Organization Leader, Endoscopic Alternatives Division. “We are also planning for the upcoming and following our vision of putting CRC in the heritage publications.”
Official launch at United European Gastroenterology 7 days (UEGW)
In the course of the virtual UEGW from October 11 to thirteen, ENDO-Assist will be offered to the general public for the first time. ENDO-Assist is at first and commercially being launched in Europe commencing in November, adopted soon later on by some Middle Eastern, African and Asian-Pacific countries. Japan, the Americas and China markets will adhere to at a later on time immediately after complying with regulations and regulations in each location. EVIS X1 and ENDO-Assist are manufactured by Olympus Medical Systems Corporation. The business and products names specified in this launch are the trademarks or registered trademarks of Olympus.
*one Products Name: Endoscopy CAD method
*2 Corley, D.A. Jensen, C.D. Marks, A.R. et al. Adenoma Detection Charge and Threat of Colorectal Cancer and Death. N Engl J Med. 2014 370: 1298-1306. Available at: https://www.ncbi.nlm.nih.gov/pmc/content articles/PMC4036494/. Accessed in October 2020
*3 When compared to WLI (white light imaging) without CADe
Olympus is passionate about the options it creates for the health care, existence sciences, and industrial gear industries, as properly as cameras and audio products and solutions. For much more than 100 yrs, Olympus has focused on generating people’s life healthier, safer, and much more fulfilling by aiding detect, stop, and deal with sickness, furthering scientific investigate, guaranteeing general public basic safety, and capturing visuals of the entire world.
Olympus Endoscopic Alternatives makes use of revolutionary capabilities in health care technology, therapeutic intervention, and precision producing to assist health care gurus provide diagnostic, therapeutic, and minimally invasive methods to increase clinical results, lessen general costs, and enrich the good quality of existence for individuals. Commencing with the world’s first gastrocamera in 1950, Olympus’ endoscopic portfolio has developed to contain endoscopes, laparoscopes, and online video imaging systems, as properly as systems integration options and health care services.